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Acute Disseminated Encephalomyelitis In A Middle Age Female
ABSTRACT:
Acute disseminated encephalomyelitis (ADEM) is an autoimmune condition that predominately involve 
demyelination of the white matter of the brain and spinal cord. It resembles other acute demyelinating syndromes like 
multiple sclerosis and most often presents in childhood.This is a case of a 52-year woman, presented with lower limb 
weakness, confusion and spasticity throughout the body with no preceding illness. CSF showed increased proteins 
with no oligoclonal bands. MRI Brain showed abnormal high intensity areas in bilateral parietal, periventricular 
region, with no contrast enhancement. She was given 1gram iv methylprednisolone based on the diagnosis of ADEM 
and responded well.
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INTRODUCTION:
Acute disseminated encephalomyelitis (ADEM) is a 
monophasic autoimmune inﬂammatory demyelinating 
disease of brain and spinal cord. Mostly young and 
adolescent children are affected and the documented 
incidence is 0.8 per 100 000 population per year (1). 
The autoimmune response to myelin basic protein that 
is T-cell mediated, triggered by an infection or 
vaccination, underlies its pathogenesis (2). The 
differentiation of ADEM from a ﬁrst attack of multiple 
sclerosis is crucial as it has both prognostic and 
therapeutic implications. MRI ﬁndings can be a helpful 
tool to label ADEM and high dose steroids is the 
treatment of choice for ADEM. Other options like 
immunosuppressants, plasmapheresis and iv 
immunoglobulins are given in refractory cases. 
CASE REPORT:
This is a case report of a 52 years old diabetic female 
presented with complaints oﬁnability to walk 
secondary to progressive lower limb weakness and 
dysphagia for 1 month and generalized body stiffness 
for 1 week.She was unable to walk for 1 monthneither 
she could perform her daily chores. There was no 
history of paresthesia or pain in legs, no history 
ofpreceding viral i l lness or vaccination. On 
examination; she was vitally stable,but confused. Her 
pupils were bilateral equally reactive to light, 
extraocular movements were normal, uvula centrally 
placed but gag reﬂex was poor.All sensory modalities 
of both upper and lower limbs were intact, with no 
fasciculations. Muscle bulk was normal in all four 
limbs, with a power of 3/5, hypertonia and brisk 
reﬂexes with no clonus in all four limbs, and the 
plantars were bilaterally down going. Cerebellar 
examinationcouldn't be done because of stiffness of 
limbs. Signs of meningeal irritation were absent. Her 
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lab workup showed Hb=12.9g/dl, Wbc=12.5x10 /l, 
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Platelets=310x10 /l, UCE, Calcium levels, LFTs, TSH 
and serum B12 levels were normal. Vasculitis work up 
came out  to  be normal .  CSF DR showed; 
RBC=50cells/ul, WBC=5cells/ul, sugar=69mg/dl, 
(BSR=110mg/dl) and protein-50mg/dl. CSF was 
negative for oligoclonal bands. EEG and VEP were 
normal.MRI brain was done that showed abnormal 
high intensity areas seen in bilateral parietal, 
periventricular region, these show high signals on ADC 
image. On subsequent post contrast T1 weighted 
images, no signiﬁcant enhancement is noted in such 
a reas ,  ﬁnd ings  a re  sugges t i ve  o f  ACUTE 
DISSEMINATED ENCEPHALOMYELITIS. (ﬁg a-c)
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Mri Showing High Intensity Areas In 
B/l Parietal, Periventricular Regions
medicines[4].There-fore it can also be named as post-
infectious encephalomyelitis and immune-mediated 
e n c e p h a l o m y e l i t i s .  A c u t e  d i s s e m i n a t e d 
encephalomyelitis has an annual reported incidence 
of0.4–0.8 per 100,000 [5,6]. Children and young adults 
are commonly affected in winter and spring 
season[5,6]. There is no gender predominance and the 
mean age at the onset of symptoms is 6-8 years [7, 8]. 
The survival rate with minor residual disability is 70 to 
90%, while complete recovery is seen in 50 to 75% 
cases, with the mortality rate of 5% [6].
ADEM is a monophasic disease. It manifests clinically 
as sudden onset multifocal neurologic deﬁcit including 
seizure disorder, motor, sensory and visual ﬁeld 
defects, aphasia, movement disorders, impaired 
sensorium,and psychosis [9]. Our patient presented 
with both lower limbs weakness, dysphagia, rigidity 
and confusion. But the diagnostic dilemma in our case 
is that there is no clinical evidence of any previous 
illness or immunization, as the acute phase of ADEM 
presents about 4–21 days after the preceding infection 
[9].The diagnosis is made on the basis of exclusion, as 
it is difﬁcult to differentiate clinically between ADEM 
and viral encephalomyelitis. MRI is a very useful tool in 
diagnosing ADEM. The MRI, T2 images shows 
widespread lesions consistent with inﬂammation, 
demyelination and edema in the white matter, basal 
ganglia, thalamus, and brainstem [7].CSF protein can 
be mildly elevated, sometimes with lymphocytic 
predominance. The presence of ol igoclonal 
immunological bands, IgG or myelin basic protein 
(MBP) does not add to the diagnosis of ADEM [10]. 
There are non-speciﬁcfeatures on EEG, and VEP 
shows delayed responses. Our patient's brain MRI 
ﬁndings are very suggestive of ADEM, while the CSF 
studies are normal, and oligoclonal bands not detected 
along with normal VEP results are adding to the 
diagnosis of ADEM rather than MS.
The treatment of choice is high doses of intravenous 
cort icosteroids [11] l ike methylprednisolone 
(20–30 mg/kg/day) for 3–5 days followed by oral 
prednisolone tapered over 4–6 weeks. There are high 
chances of relapse if steroids are tapered before three 
weeks[12, 13]. The second line treatment is 
in t ravenous  immunog lobu l in ,  i f  h igh-dose 
corticosteroids use is contraindicated or the disease is 
refractory to steroids. However, plasmapheresis is 
recommended in severe cases [11, 14].The 
immunosuppressive drugs like cyclophosphamide and 
mitoxantrone are the alternate treatment options in 
refractory cases [6].  Decompressive craniotomy is 
done in cases of intracranial hypertension [15]. Our 
patient responded well to high dose steroid therapy 
and clinically improved. 
During hospital stay initial suspicion was Parkinson's 
disease due to increased rigidity and mask like face. 
Initially patient was given supportive treatment, 
physiotherapy and anti-Parkinson drugs. As MRI 
BRAIN revealed thediagnosis of Acute Disseminated 
Encephalomyelitis (ADEM), the patient was started on 
intravenous methylprednisolone 1gram per 
day.Patient was improved on third day of intravenous 
steroids and her rigidity improved and she started 
responding to commands. She was discharged on oral 
steroids and was called for follow-up.Her symptoms 
did not recur over a follow up duration for 6 months. 
Keeping this in view, the diagnosis of ADEM is much 
strengthen as compared to other diseases mimicking 
ADEM on radiological basis like Adult onset 
leukodystrophies, CNS lymphoma and PML.
DISCUSSION:
Acute disseminated encephalomyelitis (ADEM) is an 
autoimmune disease that predominantly involve the 
white matter of brain and spinal cord [3].The triggering 
factors are bacterial, viral or parasitic infections, after 
i m m u n i z a t i o n  o r  a f t e r  t a k i n g  s o m e  
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